A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.

<h4>Background</h4>Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with around 9% of patients surviving >5 years. Asymptomatic in its initial stages, PDAC is mostly diagnosed late, when already a locally advanced or metastatic disease, as there are no useful b...

Full description

Bibliographic Details
Main Authors: Silvana Debernardi, Harrison O'Brien, Asma S Algahmdi, Nuria Malats, Grant D Stewart, Marija Plješa-Ercegovac, Eithne Costello, William Greenhalf, Amina Saad, Rhiannon Roberts, Alexander Ney, Stephen P Pereira, Hemant M Kocher, Stephen Duffy, Oleg Blyuss, Tatjana Crnogorac-Jurcevic
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-12-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1003489